Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.
Rivas EI, Linares J, Zwick M, Gómez-Llonin A, Guiu M, Labernadie A, Badia-Ramentol J, Lladó A, Bardia L, Pérez-Núñez I, Martínez-Ciarpaglini C, Tarazona N, Sallent-Aragay A, Garrido M, Celià-Terrassa T, Burgués O, Gomis RR, Albanell J, Calon A. Rivas EI, et al. Among authors: tarazona n. Nat Commun. 2022 Sep 9;13(1):5310. doi: 10.1038/s41467-022-32782-3. Nat Commun. 2022. PMID: 36085201 Free PMC article.
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression.
Martinez-Ciarpaglini C, Oltra S, Roselló S, Roda D, Mongort C, Carrasco F, Gonzalez J, Santonja F, Tarazona N, Huerta M, Espí A, Ribas G, Ferrández A, Navarro S, Cervantes A. Martinez-Ciarpaglini C, et al. Among authors: tarazona n. Mod Pathol. 2019 Feb;32(2):306-313. doi: 10.1038/s41379-018-0124-5. Epub 2018 Sep 11. Mod Pathol. 2019. PMID: 30206410 Free article.
Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma.
Gambardella V, Fleitas T, Tarazona N, Cejalvo JM, Gimeno-Valiente F, Martinez-Ciarpaglini C, Huerta M, Roselló S, Castillo J, Roda D, Cervantes A. Gambardella V, et al. Among authors: tarazona n. Ann Oncol. 2019 Aug 1;30(8):1254-1264. doi: 10.1093/annonc/mdz143. Ann Oncol. 2019. PMID: 31046106 Free article.
Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications.
Martinez-Ciarpaglini C, Fleitas-Kanonnikoff T, Gambardella V, Llorca M, Mongort C, Mengual R, Nieto G, Navarro L, Huerta M, Rosello S, Roda D, Tarazona N, Navarro S, Ribas G, Cervantes A. Martinez-Ciarpaglini C, et al. Among authors: tarazona n. ESMO Open. 2019 May 27;4(3):e000470. doi: 10.1136/esmoopen-2018-000470. eCollection 2019. ESMO Open. 2019. PMID: 31231566 Free PMC article.
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.
Tarazona N, Gimeno-Valiente F, Gambardella V, Zuñiga S, Rentero-Garrido P, Huerta M, Roselló S, Martinez-Ciarpaglini C, Carbonell-Asins JA, Carrasco F, Ferrer-Martínez A, Bruixola G, Fleitas T, Martín J, Tébar-Martínez R, Moro D, Castillo J, Espí A, Roda D, Cervantes A. Tarazona N, et al. Ann Oncol. 2019 Nov 1;30(11):1804-1812. doi: 10.1093/annonc/mdz390. Ann Oncol. 2019. PMID: 31562764 Free article.
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella V, Castillo J, Tarazona N, Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló S, Roda D, Huerta M, Cervantes A, Fleitas T. Gambardella V, et al. Among authors: tarazona n. Cancer Treat Rev. 2020 Jun;86:102015. doi: 10.1016/j.ctrv.2020.102015. Epub 2020 Mar 23. Cancer Treat Rev. 2020. PMID: 32248000 Free article. Review.
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer.
Tarazona N, Gimeno-Valiente F, Gambardella V, Huerta M, Roselló S, Zuniga S, Calon A, Carbonell-Asins JA, Fontana E, Martinez-Ciarpaglini C, Eason K, Rentero-Garrido P, Fleitas T, Papaccio F, Moro-Valdezate D, Nyamundanda G, Castillo J, Espí A, Sadanandam A, Roda D, Cervantes A. Tarazona N, et al. ESMO Open. 2020 Sep;5(5):e000847. doi: 10.1136/esmoopen-2020-000847. ESMO Open. 2020. PMID: 32967918 Free PMC article.
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma.
Cabeza-Segura M, Gambardella V, Gimeno-Valiente F, Carbonell-Asins JA, Alarcón-Molero L, González-Vilanova A, Zuñiga-Trejos S, Rentero-Garrido P, Villagrasa R, Gil M, Durá A, Richart P, Alonso N, Huerta M, Roselló S, Roda D, Tarazona N, Martínez-Ciarpaglini C, Castillo J, Cervantes A, Fleitas T. Cabeza-Segura M, et al. Among authors: tarazona n. Br J Cancer. 2022 Dec;127(12):2198-2206. doi: 10.1038/s41416-022-02005-z. Epub 2022 Oct 17. Br J Cancer. 2022. PMID: 36253523 Free PMC article.
83 results